Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01026441 · ClinicalTrials.gov registry record · Phase 4
Clinical Study to Evaluate the Safety and Efficacy of the Vela100
A Phase 4 study, sponsored by Syneron Medical.
- Terminated
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
NCT01026441 is a Phase 4 study that was terminated before completion, run by Syneron Medical. The registered enrollment target is 60 participants.
The verdict
NCT01026441, a Phase 4 study, was terminated before completion, sponsored by Syneron Medical.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
Study Summary
This study is intended to test the safety of the Vela100 device when used for treatment for cellulite and circumference temporary reduction.
Interventions
- DEVICE Vela100 (Aesthetic)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2008-10 |
| Est. Completion | 2008-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01026441
The ClinicalTrials.gov registry entry for NCT01026441 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Syneron Medical, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vela100 (Aesthetic) is the first listed.
NCT01026441 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01026441 about?
NCT01026441 is a clinical study titled "Clinical Study to Evaluate the Safety and Efficacy of the Vela100". This study is intended to test the safety of the Vela100 device when used for treatment for cellulite and circumference temporary reduction.
What is the current status of trial NCT01026441?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2008-10. Estimated completion is 2008-10.
What interventions are being tested in trial NCT01026441?
The interventions under investigation include: Vela100 (Aesthetic) (DEVICE).
Who is sponsoring clinical trial NCT01026441?
This trial is sponsored by Syneron Medical, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.